Viewing Study NCT02057003

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:43 PM
Ignite Modification Date: 2026-02-20 @ 6:25 PM
Study NCT ID: NCT02057003
Status: UNKNOWN
Last Update Posted: 2016-10-17
First Post: 2014-01-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients
Sponsor: Valme University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C, Chronic View
None Human Immunodeficiency Virus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV View
None hepatitis C virus View
None sustained virologic response View
None telaprevir View
None boceprevir View
None simeprevir View
None sofosbuvir View
None daclatasvir View
None paritaprevir View
None pegylated interferon View
None ribavirin View
None direct-acting antivirals View
None dasabuvir View
None ombitasvir View
None ledipasvir View
None velpatasvir View
None grazoprevir View
None elbasvir View